Salomon Azoulay's most recent trade in MBX Biosciences Inc. was a trade of 55,000 Stock option (right to buy) done . Disclosure was reported to the exchange on May 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2026 | 55,000 | 194,540 | - | - | Stock option (right to buy) | |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 38.38 per share. | 08 May 2026 | 55,000 | 14,769 | - | 38.4 | 2,110,900 | Common Stock |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.46 per share. | 08 May 2026 | 55,000 | 69,769 | - | 10.5 | 575,300 | Common Stock |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2026 | 15,003 | 30,008 | - | - | Stock option (right to buy) | |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 38.30 per share. | 08 May 2026 | 15,003 | 14,769 | - | 38.3 | 574,615 | Common Stock |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 08 May 2026 | 15,003 | 29,772 | - | 16 | 240,048 | Common Stock |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.54 per share. | 06 May 2026 | 231 | 14,769 | - | 29.5 | 6,824 | Common Stock |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 70,000 | 70,000 | - | - | Stock option (right to buy) | |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 15,000 | 15,000 | - | 0 | Common Stock | |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| MBX Biosciences Inc | Salomon Azoulay | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 45,011 | 45,011 | - | - | Stock Option (Right to Buy) |